Shionogi and MPP sign licence agreement for COVID-19 oral antiviral treatment
Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.
Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.
Sause will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023.
The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.
Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally
Julie Brown is currently Chief Operating and Financial Officer, Burberry Group.
He is a seasoned professional having worked in reputed corporates in API business with over 35+ years of experience covering manufacturing, general management, and business
Sud has more than 32 years of work experience with different companies like Clivient, Jubilant Life Sciences, Piramal Enterprises, Parabolic Drugs, Orchid Chemicals and Pharmaceuticals, Ranbaxy Labs, and Lupin
AB PMJAY has been successful in providing quality health services to the beneficiaries who come from weak financial backgrounds
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
Subscribe To Our Newsletter & Stay Updated